|
PAPD5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.890800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.564400E-01 |
| Normal-vs-Stage2 |
7.940200E-01 |
| Normal-vs-Stage3 |
9.556000E-01 |
| Normal-vs-Stage4 |
2.167400E-01 |
| Stage1-vs-Stage2 |
6.298000E-01 |
| Stage1-vs-Stage3 |
7.637000E-01 |
| Stage1-vs-Stage4 |
4.119800E-01 |
| Stage2-vs-Stage3 |
8.493600E-01 |
| Stage2-vs-Stage4 |
3.563200E-01 |
| Stage3-vs-Stage4 |
3.735600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.672800E-01 |
| Normal-vs-AfricanAmerican |
1.901430E-01 |
| Normal-vs-Asian |
9.294200E-01 |
| Caucasian-vs-AfricanAmerican |
1.667410E-01 |
| Caucasian-vs-Asian |
9.507800E-01 |
| AfricanAmerican-vs-Asian |
5.378600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.004400E-01 |
| Normal-vs-Female |
9.208400E-01 |
| Male-vs-Female |
6.838400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.142970E-01 |
| Normal-vs-Extreme_Weight |
1.285640E-01 |
| Normal-vs-Obese |
7.152400E-01 |
| Normal-vs-Extreme_Obese |
8.682000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.928200E-01 |
| Normal_Weight-vs-Obese |
1.208990E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.272800E-01 |
| Extreme_Weight-vs-Obese |
1.457190E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.898800E-01 |
| Obese-vs-Extreme_Obese |
9.961600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.506200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.161600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.495000E-01 |
| Normal-vs-Age(81-100Yrs) |
1.557400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.703800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.816000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.633200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.972000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.770100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.111000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.182400E-01 |
| Normal-VS-Type2 PRCC |
9.626000E-01 |
| Normal-VS-KIRP CIMP |
5.248200E-01 |
| Normal-VS-Unclassified PRCC |
4.717400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.837800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.233800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.350200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.650400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.124000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.400000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.950800E-01 |
| Normal-vs-N1 |
8.053200E-01 |
| Normal-vs-N2 |
3.089800E-02 |
| N0-vs-N1 |
6.923000E-01 |
| N0-vs-N2 |
2.688000E-02 |
| N1-vs-N2 |
6.827700E-02 |
|
|
